These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 26239720)

  • 1. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
    Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
    Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements.
    Meggyes M; Nagy DU; Balassa T; Godony K; Peterfalvi A; Szereday L; Polgar B
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy.
    Meggyes M; Miko E; Polgar B; Bogar B; Farkas B; Illes Z; Szereday L
    PLoS One; 2014; 9(3):e92371. PubMed ID: 24651720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.
    Rusakiewicz S; Semeraro M; Sarabi M; Desbois M; Locher C; Mendez R; Vimond N; Concha A; Garrido F; Isambert N; Chaigneau L; Le Brun-Ly V; Dubreuil P; Cremer I; Caignard A; Poirier-Colame V; Chaba K; Flament C; Halama N; Jäger D; Eggermont A; Bonvalot S; Commo F; Terrier P; Opolon P; Emile JF; Coindre JM; Kroemer G; Chaput N; Le Cesne A; Blay JY; Zitvogel L
    Cancer Res; 2013 Jun; 73(12):3499-510. PubMed ID: 23592754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway.
    Sun J; Yang M; Ban Y; Gao W; Song B; Wang Y; Zhang Y; Shao Q; Kong B; Qu X
    PLoS One; 2016; 11(1):e0147186. PubMed ID: 26789128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders.
    de Kivit S; Lempsink LJ; Plants J; Martinson J; Keshavarzian A; Landay AL
    Clin Immunol; 2015 Jan; 156(1):28-35. PubMed ID: 25450337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early transient suppression of immune checkpoint proteins T-cell immunoglobulin mucin-3 and programmed cell death-1 in peripheral blood lymphocytes after blastocyst transfer is associated with successful implantation.
    Zhang T; Zhu W; Zhao Y; Cheung WC; Liu Y; Chen X; Du Y; Leung KT; Chan YL; Wang CC; Laird S; Li TC
    Fertil Steril; 2020 Aug; 114(2):426-435. PubMed ID: 32199622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Galectin-9/TIM-3 pathway in the systemic inflammatory response in early-onset preeclampsia.
    Miko E; Meggyes M; Bogar B; Schmitz N; Barakonyi A; Varnagy A; Farkas B; Tamas P; Bodis J; Szekeres-Bartho J; Illes Z; Szereday L
    PLoS One; 2013; 8(8):e71811. PubMed ID: 23936526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C.
    Szereday L; Meggyes M; Berki T; Miseta A; Farkas N; Gervain J; Par A; Par G
    Clin Exp Med; 2020 May; 20(2):219-230. PubMed ID: 32108916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
    Linedale R; Schmidt C; King BT; Ganko AG; Simpson F; Panizza BJ; Leggatt GR
    PLoS One; 2017; 12(4):e0175755. PubMed ID: 28423034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
    Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
    Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Distribution of TIM-3
    Zhuang C; Ni B; Zhang ZZ; Zhao WY; Tu L; Ma XL; Yang LX; Cao H; Wang M
    J Immunol Res; 2021; 2021():6647292. PubMed ID: 33681387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy.
    Meggyes M; Lajko A; Palkovics T; Totsimon A; Illes Z; Szereday L; Miko E
    Placenta; 2015 Oct; 36(10):1153-60. PubMed ID: 26278059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
    Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
    Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival.
    van Esch EM; van Poelgeest MI; Kouwenberg S; Osse EM; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH
    Int J Cancer; 2015 Feb; 136(4):E95-106. PubMed ID: 25220367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIM-3 does not act as a receptor for galectin-9.
    Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
    PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
    Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
    Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
    Qiu MK; Wang SC; Dai YX; Wang SQ; Ou JM; Quan ZW
    PLoS One; 2015; 10(6):e0128523. PubMed ID: 26035207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.
    Seifert AM; Zeng S; Zhang JQ; Kim TS; Cohen NA; Beckman MJ; Medina BD; Maltbaek JH; Loo JK; Crawley MH; Rossi F; Besmer P; Antonescu CR; DeMatteo RP
    Clin Cancer Res; 2017 Jan; 23(2):454-465. PubMed ID: 27470968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.